CLINICAL TRIALS

In the United States, a clinical trial is underway to evaluate the effectiveness and safety of the Amigo System. The clinical plan, approved by the FDA, involves up to 10 centers and 197 subjects who are scheduled for a right-sided EP mapping procedure for typical Atrial Flutter, AVNRT, right-sided accessory pathway, or Ventricular Tachycardia.

To learn more about the current Clinical Trial, you can visit:
clincaltrials.gov or contact us.

Future clinical trials are planned for additional indications.

Clinical Trial Investigators, log in here.